Sorensen Mel

Sorensen Mel is listed in filings as President and CEO at Galera Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 24, 2025, including sale activity. Recent filings connect the profile to Galera Therapeutics, Inc. (GRTX). The current snapshot covers public activity from Aug 20, 2024 to Nov 24, 2025. Reported amounts are shown as $1.4K to $4.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.